Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS)

INR 50.32

(4.77%)

Operating Income Summary of Aarey Drugs & Pharmaceuticals Limited

  • Aarey Drugs & Pharmaceuticals Limited's latest annual operating income in 2023 was 2.83 Million INR , down -58.86% from previous year.
  • Aarey Drugs & Pharmaceuticals Limited's latest quarterly operating income in 2024 Q1 was 7.12 Million INR , up 240.55% from previous quarter.
  • Aarey Drugs & Pharmaceuticals Limited reported an annual operating income of 66.92 Million INR in 2022, down -33.26% from previous year.
  • Aarey Drugs & Pharmaceuticals Limited reported an annual operating income of 100.26 Million INR in 2021, up 21.82% from previous year.
  • Aarey Drugs & Pharmaceuticals Limited reported a quarterly operating income of 27.53 Million INR for 2023 FY, down -58.86% from previous quarter.
  • Aarey Drugs & Pharmaceuticals Limited reported a quarterly operating income of 9.22 Million INR for 2023 Q1, down -70.83% from previous quarter.

Annual Operating Income Chart of Aarey Drugs & Pharmaceuticals Limited (2023 - 2007)

Historical Annual Operating Income of Aarey Drugs & Pharmaceuticals Limited (2023 - 2007)

Year Operating Income Operating Income Growth
2023 2.83 Million INR -58.86%
2022 66.92 Million INR -33.26%
2021 100.26 Million INR 21.82%
2020 82.3 Million INR 29.54%
2019 63.53 Million INR -30.4%
2018 91.29 Million INR 25.34%
2017 72.83 Million INR -8.71%
2016 79.78 Million INR 340.07%
2015 18.12 Million INR 28.58%
2014 14.09 Million INR 5.14%
2013 13.41 Million INR 48.59%
2012 9.02 Million INR 119.53%
2011 4.11 Million INR -58.7%
2010 9.95 Million INR 4.67%
2009 9.51 Million INR -16.93%
2008 11.45 Million INR 56.25%
2007 7.32 Million INR 0.0%

Peer Operating Income Comparison of Aarey Drugs & Pharmaceuticals Limited

Name Operating Income Operating Income Difference
Alembic Pharmaceuticals Limited 5.75 Billion INR 99.951%
Hester Biosciences Limited 364.77 Million INR 99.224%
Aarti Drugs Limited 7.14 Billion INR 99.96%
Aarti Pharmalabs Limited 3.12 Billion INR 99.91%
Albert David Limited 1.33 Billion INR 99.788%
Alembic Limited 767.77 Million INR 99.631%
Alkem Laboratories Limited 19.46 Billion INR 99.985%
Bafna Pharmaceuticals Limited 237.66 Million INR 98.809%
Bajaj HealthCare Limited - INR -Infinity%
Biofil Chemicals and Pharmaceuticals Limited 20.65 Million INR 86.295%
Brooks Laboratories Limited -72.25 Million INR 103.918%
Eris Lifesciences Limited 5.18 Billion INR 99.945%
FDC Limited 3.03 Billion INR 99.907%
Glenmark Life Sciences Limited 8.97 Billion INR 99.968%
Gufic Biosciences Limited 2.89 Billion INR 99.902%
Hikal Limited 1.49 Billion INR 99.811%
Ind-Swift Limited 1.22 Billion INR 99.769%
Innova Captab Limited 2.53 Billion INR 99.888%
IOL Chemicals and Pharmaceuticals Limited 4.94 Billion INR 99.943%
Jagsonpal Pharmaceuticals Limited 214.04 Million INR 98.677%
Jubilant Pharmova Limited 5.18 Billion INR 99.945%
Lincoln Pharmaceuticals Limited 1.9 Billion INR 99.852%
Lupin Limited 27.75 Billion INR 99.99%
Mangalam Drugs & Organics Limited 27.45 Million INR 89.69%
Medico Remedies Limited 277.11 Million INR 98.978%
Morepen Laboratories Limited 4.17 Billion INR 99.932%
Nectar Lifesciences Limited 3.89 Billion INR 99.927%
Orchid Pharma Limited 2.36 Billion INR 99.88%
Procter & Gamble Health Limited 2.78 Billion INR 99.898%
RPG Life Sciences Limited 2.29 Billion INR 99.877%
Kilitch Drugs (India) Limited 208.05 Million INR 98.639%
Sigachi Industries Limited 1.47 Billion INR 99.808%
Solara Active Pharma Sciences Limited -3.85 Billion INR 100.073%
Suven Pharmaceuticals Limited 4.6 Billion INR 99.939%
Themis Medicare Limited 1.3 Billion INR 99.783%
Unichem Laboratories Limited - INR -Infinity%
Vaishali Pharma Limited 6.29 Million INR 55.023%
Wanbury Limited 1.7 Billion INR 99.834%
Windlas Biotech Limited 1.29 Billion INR 99.782%
ZIM Laboratories Limited 1.09 Billion INR 99.742%
Ind-Swift Laboratories Limited 2 Billion INR 99.859%
Ipca Laboratories Limited 29.59 Billion INR 99.99%
Sun Pharmaceutical Industries Limited 104.3 Billion INR 99.997%
Venus Remedies Limited 534.65 Million INR 99.471%
Sakar Healthcare Limited 495.5 Million INR 99.429%
Aurobindo Pharma Limited 104.5 Billion INR 99.997%
Divi's Laboratories Limited 18.31 Billion INR 99.985%
AstraZeneca Pharma India Limited 4.47 Billion INR 99.937%
Mankind Pharma Limited 40.86 Billion INR 99.993%
Sequent Scientific Limited - INR -Infinity%
Laurus Labs Limited 3.94 Billion INR 99.928%
Neuland Laboratories Limited 5.31 Billion INR 99.947%
J. B. Chemicals & Pharmaceuticals Limited 7.54 Billion INR 99.962%
Glenmark Pharmaceuticals Limited 6.5 Billion INR 99.956%
Zydus Lifesciences Limited 45.39 Billion INR 99.994%
Amrutanjan Health Care Limited 621.02 Million INR 99.544%
Wockhardt Limited 140 Million INR 97.978%
Bal Pharma Limited 214.56 Million INR 98.681%
Dr. Reddy's Laboratories Limited 67.72 Billion INR 99.996%
Bliss GVS Pharma Limited 1.23 Billion INR 99.77%
Par Drugs and Chemicals Limited 551.58 Million INR 99.487%
Caplin Point Laboratories Limited 7.22 Billion INR 99.961%
Shilpa Medicare Limited 3.76 Billion INR 99.925%
Valiant Laboratories Limited - INR -Infinity%
Ajanta Pharma Limited 19.67 Billion INR 99.986%
Granules India Limited 6.52 Billion INR 99.957%
Medicamen Biotech Limited - INR -Infinity%
Syncom Formulations (India) Limited 249.25 Million INR 98.864%
Piramal Enterprises Limited - INR -Infinity%
Torrent Pharmaceuticals Limited 25.33 Billion INR 99.989%
NATCO Pharma Limited 25.96 Billion INR 99.989%
Suven Life Sciences Limited -1.22 Billion INR 100.231%
Krebs Biochemicals & Industries Limited - INR -Infinity%
Strides Pharma Science Limited 5.22 Billion INR 99.946%
Indoco Remedies Limited 1.52 Billion INR 99.814%
Alpa Laboratories Limited 61.51 Million INR 95.398%
Lasa Supergenerics Limited -458 Million INR 100.618%
Sun Pharma Advanced Research Company Limited -4.11 Billion INR 100.069%